1-Piperidinecarboxylic acid, 4-[[[4-[(2-methylbenzoyl)amino]-1-naphthalenyl]sulfonyl]amino]-, ethyl ester manufacturers
- CCR8 antagonist 1
-
- $30.00
-
2026-07-27
- CAS:723304-76-5
- Purity: 99.51%
- Supply Ability: 10g
|
| | 1-Piperidinecarboxylic acid, 4-[[[4-[(2-methylbenzoyl)amino]-1-naphthalenyl]sulfonyl]amino]-, ethyl ester Basic information |
| | 1-Piperidinecarboxylic acid, 4-[[[4-[(2-methylbenzoyl)amino]-1-naphthalenyl]sulfonyl]amino]-, ethyl ester Chemical Properties |
| density | 1.34±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 25 mg/mL (50.44 mM; Need ultrasonic) | | form | Solid | | pka | 11.41±0.20(Predicted) | | color | White to off-white |
| | 1-Piperidinecarboxylic acid, 4-[[[4-[(2-methylbenzoyl)amino]-1-naphthalenyl]sulfonyl]amino]-, ethyl ester Usage And Synthesis |
| Uses | CCR8 antagonist 1 (compound 15) is a potente human CCR8 antagonist with a Ki of 1.6 nM[1]. | | Biological Activity | CCR8 antagonist 1 (compound 15) is a potente human CCR8 antagonist with a Ki of 1.6 nM[1]. | | IC 50 | CCR8: 1.6 nM (Ki) | | References | [1]. Jenkins TJ, et al. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem. 2007;50(3):566-584. |
| | 1-Piperidinecarboxylic acid, 4-[[[4-[(2-methylbenzoyl)amino]-1-naphthalenyl]sulfonyl]amino]-, ethyl ester Preparation Products And Raw materials |
|